Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1995
12/28/1995WO1995035316A1 New opioid peptide antagonists
12/28/1995WO1995035308A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
12/28/1995WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
12/28/1995WO1995035297A1 Novel substituted purinyl derivatives with immunomodulating activity
12/28/1995WO1995035113A1 USE OF FERROUS (III) OXYDE (Fe2O3) FOR THE TREATMENT OF IMMUNE DEFICIENCIES ESPECIALLY AIDS
12/28/1995WO1995035105A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide
12/28/1995CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
12/28/1995CA2193100A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide
12/28/1995CA2193092A1 Antibodies against t cells as therapeutics
12/28/1995CA2192484A1 New opioid peptide antagonists
12/27/1995EP0688771A1 Use of lactam compounds as pharmaceutical agents
12/27/1995EP0688766A1 Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them
12/27/1995EP0688362A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
12/27/1995EP0688338A1 T cell epitopes of ryegrass pollen allergen
12/27/1995EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders
12/27/1995EP0688331A1 New sulfated lyso-ganglioside derivatives
12/27/1995EP0688330A1 New o-sulfated gangliosides and lyso-ganglioside derivatives
12/27/1995EP0688314A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
12/27/1995EP0688224A1 A mutant protein and methods and materials for making and using it
12/27/1995EP0688217A1 Heterocycle-containing macrocyclic immunomodulators
12/27/1995EP0688211A1 Methods and compositions for inhibition of angiogenesis
12/27/1995EP0379549B1 Endotoxin binding protein and uses thereof
12/26/1995US5478941 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine
12/26/1995US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors
12/26/1995US5478856 Styrene derivatives and salts thereof
12/26/1995US5478844 Method of using aminocoumaran derivatives for treating cerebrovascular diseases
12/26/1995US5478842 Antiinflammatory agents, antiallergens, drugs for treatment of diseases mediated by leukotrienes
12/26/1995US5478827 Pyrazole derivatives
12/26/1995US5478822 Antiallergens, antiinflammatory, cardiovascular agents
12/26/1995CA2021534C Antiallergic spray preparations
12/25/1995CA2152432A1 Use of a lactam compound as pharmaceutically active ingredient
12/21/1995WO1995034638A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells
12/21/1995WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
12/21/1995WO1995034568A1 Aryl, alkyl, alkenyl, and alkynylmacrolides
12/21/1995WO1995034565A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them
12/21/1995WO1995034563A1 Pyrazolo and pyrrolopyridines
12/21/1995WO1995034561A1 Benzoylecgonine, ecgonine and ecgonidine derivatives
12/21/1995WO1995034555A1 Benzimidazolone derivatives with central dopaminergic activity
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995WO1995034323A2 Proteinaceous adjuvants
12/21/1995WO1995034321A1 Immune modulation with class ii alpha-chain fragments
12/21/1995WO1995034320A2 Methods for inhibiting antigen specific t cell responses
12/21/1995WO1995034312A1 Constrained peptides
12/21/1995WO1995034300A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same
12/21/1995WO1995034202A1 Methods for reducing hyperacute rejection of xenografts
12/21/1995WO1995032731A3 Immunogenic pharmaceuticals
12/21/1995WO1995030761A3 Methods of in vivo gene delivery
12/21/1995WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
12/21/1995WO1995020660A3 Immunization by inoculation of dna transcription unit
12/21/1995CA2192972A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them
12/21/1995CA2192660A1 Methods for reducing hyperacute rejection of xenografts
12/21/1995CA2192655A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells
12/21/1995CA2192454A1 Use of genetically detoxified pertussis toxin as an adjuvant
12/21/1995CA2192338A1 Aryl, alkyl, alkenyl, and alkynylmacrolides
12/21/1995CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995CA2191733A1 Methods for inhibiting antigen specific t cell responses
12/21/1995CA2191479A1 Constrained peptides
12/21/1995CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives
12/21/1995CA2169762A1 Immune modulation with class ii alpha-chain fragments
12/20/1995EP0687911A2 Methods for assaying endotoxin concentration
12/20/1995EP0687467A2 Cosmetic and dermatological combinations containing glycerylalkylethers as active ingredients
12/20/1995EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION
12/20/1995EP0687182A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
12/20/1995EP0687179A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders
12/20/1995EP0687177A1 Use of lamotrigine for treating aids-related neural disorders
12/20/1995EP0687176A1 Use of riluzole for treating aids-related neural disorders
12/20/1995EP0529032B1 Process for the continuous extraction of peat and apparatus for carrying out the process
12/20/1995EP0502036B1 Latency associated peptide and uses therefor
12/20/1995CN1113518A A novel peptide related to human programmed cell death and DNA encoding it
12/19/1995US5476870 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
12/19/1995US5476861 Treating allergic diseases
12/19/1995US5476860 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics
12/19/1995CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337767C Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
12/19/1995CA1337763C Staurosporine derivatives with substituted methylamino nitrogen
12/14/1995WO1995033997A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
12/14/1995WO1995033823A1 Methods for selectively stimulating proliferation of t cells
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/14/1995WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995WO1995033751A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
12/14/1995WO1995033750A1 Corticotropin releasing factor antagonists
12/14/1995WO1995033744A1 Tachykinin (nk1) receptor antagonists
12/14/1995WO1995033712A1 Anti-inflammatory compounds
12/14/1995WO1995033709A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents
12/14/1995WO1995033495A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
12/14/1995WO1995033475A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
12/14/1995WO1995033473A1 Extracts of stephania tetrandra for inhibition of interleukin-6 production
12/14/1995WO1995033459A1 Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
12/14/1995DE4412794A1 Verfahren zur Herstellung von dendritischen Zellen, so erhaltene Zellen und Behälter zur Durchführung dieses Verfahrens A process for the preparation of dendritic cells thus obtained cells and container for carrying out this method
12/14/1995CA2192468A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
12/14/1995CA2192218A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
12/14/1995CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995CA2191586A1 Methods for selectively stimulating proliferation of t cells
12/14/1995CA2187531A1 Tachykinin (nk1) receptor antagonists
12/13/1995EP0686148A1 Inhibitors of hiv reverse transcriptase
12/13/1995EP0686147A1 Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity
12/13/1995EP0686042A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
12/13/1995EP0610372B1 1,3-dihydro-2h-imidazo(4,5-b)quinolin-2-one derivatives as phosphodiesterase inhibitors
12/12/1995US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity
1 ... 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 ... 1172